Cellectar Biosciences, Inc. (NASDAQ: CLRB) announces that the Japan Patent Office has granted the patent titled “Phospholipid Analogs as Diapeutic ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE